Acadia Pharmaceuticals Inc. 13F holders
Of the 44 funds followed here, 10 reported a position in Acadia Pharmaceuticals Inc. in a 13F for the quarter ended 30 June 2026. The largest: Geode Capital Management, 3.4 million shares worth $85.0 million, 0.0% of its reported book. New this quarter: Alyeska.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Geode Capital Management | 3,358,129 | $85.0 million | 0.0% | -106,560 | trimmed | 30 June 2026 | 13F |
| Point72 Asset Management | 2,461,568 | $62.3 million | 0.1% | -143,748 | trimmed | 30 June 2026 | 13F |
| Citadel Advisors | 2,283,177 | $57.8 million | 0.0% | +1,624,517 | added | 30 June 2026 | 13F |
| Norges Bank | 1,623,308 | $41.1 million | 0.0% | held | 30 June 2026 | 13F | |
| Renaissance Technologies | 1,282,596 | $32.4 million | 0.0% | -441,600 | trimmed | 30 June 2026 | 13F |
| Two Sigma Investments | 926,992 | $23.5 million | 0.0% | +151,871 | added | 30 June 2026 | 13F |
| Millennium Management | 589,924 | $14.9 million | 0.0% | -115,537 | trimmed | 30 June 2026 | 13F |
| Alyeska | 310,287 | $7.9 million | 0.0% | +310,287 | new | 30 June 2026 | 13F |
| FMR LLC | 240,384 | $6.1 million | 0.0% | -109,956 | trimmed | 30 June 2026 | 13F |
| Bridgewater Associates | 50,265 | $1.3 million | 0.0% | -91,547 | trimmed | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 7 August 2026 | 13G | State Street Corporation and 1 other | 9.1 million | 5.3% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 28 April 2026 | 13G | Vanguard Portfolio Management and 1 other | 8.8 million | 5.2% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 14 November 2025 | 13G/A | RTW Investments, LP and 3 others | 7.1 million | 4.2% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 4 September 2026 | 1,281 | $27.86 | SEC |
| 1 September 2026 | 333 | $28.91 | SEC |
| 5 August 2026 | 7 | $27.15 | SEC |
| 4 August 2026 | 1,565 | $25.61 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 1,565 on 4 August 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to ACAD by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.